Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
Camp Cyber reboots conference format with top-security KC Tech Council retreat
From cyberspace to the great outdoors, the KC Tech Council is using past success to develop a one-of-a-kind professional development experience: Camp Cyber. Traditional conferencing rebooted, the two-day retreat is expected to provide Kansas City’s top information security leaders with exclusive access to industry insiders, said Ryan Weber, KC Tech Council president. Camp Cyber –…
High-tech dog kennels to affordable housing: Mayor announces city’s new startup partners
Kansas City needs startups’ brightest minds working on the ever-evolving city’s behalf, said Mayor Sly James. Six valuable new startup partners — ranging from companies addressing housing and zoning issues to firms focused on high-tech dog houses and the management of restaurants’ grease — have accepted the call, the city announced Friday. “The Innovation Partnership…
Sickweather CEO bringing Cold Cough Flu conference to KC
It might be warm and sunny this summer, but a storm is brewing, said Graham Dodge. The Sickweather founder’s Cold Cough Flu conference set for October in Kansas City could help health officials detect what’s to come. Inspired by a similar event organized by the Centers for Disease Control and Prevention, the Oct. 15 event…
Teens’ marketing startup TRNDSTTRS aims to amplify its own business influence
Staying young and hungry is everything, said the teenage entrepreneurs at TRNDSTTRS Media. With a team of ten 18- to 19-year-old go-getters, the tech-based firm focuses on providing affordable, in-depth marketing service to small and mid-sized companies. They use their age as an advantage rather than seeing it as an obstacle, said Jake Bjorseth, founder…